GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | ADAM9 | affects expression | EXP | | 6480464 | CTD | tert-Butylhydroperoxide affects the expression of ADAM9 mRNA | PMID:23410634 | ADAM9 | increases expression | EXP | | 6480464 | CTD | tert-Butylhydroperoxide results in increased expression of ADAM9 mRNA | PMID:20847119 | ADAM9 | multiple interactions | EXP | | 6480464 | CTD | [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ADAM9 mRNA; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADAM9 mRNA]; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADAM9 mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADAM9 mRNA] | PMID:20847119 | |
Go Back to source page | Continue to Ontology report |